These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26582669)

  • 1. Re: Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
    Schaeffer EM
    J Urol; 2015 Dec; 194(6):1642. PubMed ID: 26582669
    [No Abstract]   [Full Text] [Related]  

  • 2. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?
    Gardiner BJ; Mahony AA; Ellis AG; Lawrentschuk N; Bolton DM; Zeglinski PT; Frauman AG; Grayson ML
    Clin Infect Dis; 2014 Feb; 58(4):e101-5. PubMed ID: 24170195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.
    Grayson ML; Macesic N; Trevillyan J; Ellis AG; Zeglinski PT; Hewitt NH; Gardiner BJ; Frauman AG
    Clin Infect Dis; 2015 Oct; 61(7):1141-3. PubMed ID: 26063723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline.
    Cunha BA; Gran A; Raza M
    Int J Antimicrob Agents; 2015 Apr; 45(4):427-9. PubMed ID: 25662814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.
    Reffert JL; Smith WJ
    Pharmacotherapy; 2014 Aug; 34(8):845-57. PubMed ID: 24782335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The revival of fosfomycin.
    Michalopoulos AS; Livaditis IG; Gougoutas V
    Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic studies and prostatic tissue distribution of fosfomycin tromethamine in bacterial prostatitis or normal rats.
    Fan L; Shang X; Zhu J; Ma B; Zhang Q
    Andrologia; 2018 Aug; 50(6):e13021. PubMed ID: 29718594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fosfomycin for the treatment of chronic bacterial prostatitis.
    Karaiskos I; Galani L; Sakka V; Gkoufa A; Sopilidis O; Chalikopoulos D; Alivizatos G; Giamarellou E
    J Antimicrob Chemother; 2019 May; 74(5):1430-1437. PubMed ID: 30796442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.
    Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA
    Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 11. Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.
    Poulakou G; Bassetti M; Righi E; Dimopoulos G
    Future Microbiol; 2014; 9(9):1053-69. PubMed ID: 25340835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
    Li G; Standing JF; Bielicki J; Hope W; van den Anker J; Heath PT; Sharland M
    Drugs; 2017 Jun; 77(9):941-950. PubMed ID: 28456943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the hidden potential of fosfomycin for the fight against severe Gram-negative infections.
    Saiprasad PV; Krishnaprasad K
    Indian J Med Microbiol; 2016; 34(4):416-420. PubMed ID: 27934817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
    Kollef MH; Ricard JD; Roux D; Francois B; Ischaki E; Rozgonyi Z; Boulain T; Ivanyi Z; János G; Garot D; Koura F; Zakynthinos E; Dimopoulos G; Torres A; Danker W; Montgomery AB
    Chest; 2017 Jun; 151(6):1239-1246. PubMed ID: 27890714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Commentary: Fosfomycin: The Current Status of the Drug.
    Falagas ME; Rafailidis PI
    Clin Infect Dis; 2015 Oct; 61(7):1144-6. PubMed ID: 26063717
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing.
    Schmidt JJ; Bode-Böger SM; Wilhelmi M; Omar M; Martens-Lobenhoffer J; Welte T; Kielstein JT
    J Antimicrob Chemother; 2016 Sep; 71(9):2673-4. PubMed ID: 27272722
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
    Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies.
    Antonello RM; Di Bella S; Maraolo AE; Luzzati R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1117-1126. PubMed ID: 33604721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosfomycin for bacterial prostatitis: a review.
    Kwan ACF; Beahm NP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106106. PubMed ID: 32721595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.